MétaCan
Menu
Back to cohort
Record W3195015166 · doi:10.1186/s13058-021-01450-7

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

2021· article· en· W3195015166 on OpenAlexafffund
Anna Morra, Maria Escala-Garcia, Jonathan Beesley, Renske Keeman, Sander Canisius, Thomas U. Ahearn, Irene L. Andrulis, Hoda Anton‐Culver, Volker Arndt, Paul L. Auer, Annelie Augustinsson, Laura E. Beane Freeman, Heiko Becher, Matthias W. Beckmann, Sabine Behrens, Stig E. Bojesen, Manjeet K. Bolla, Hermann Brenner, Thomas Brüning, Saundra S. Buys, Bette J. Caan, Daniele Campa, Federico Canzian, Jose E. Castelao, Jenny Chang‐Claude, Stephen J. Chanock, Ting‐Yuan David Cheng, Christine L. Clarke, Anne‐Lise Børresen‐Dale, Kristine Kleivi Sahlberg, Lars Ottestad, Rolf Kåresen, Ellen Schlichting, Marit Muri Holmen, Toril Sauer, Vilde Drageset Haakensen, Olav Engebråten, Bjørn Naume, Alexander Fosså, Cecile E. Kiserud, Kristin V. Reinertsen, Åslaug Helland, Margit Riis, Jürgen Geisler, Grethe I.G. Alnæs, Sarah V. Colonna, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Mary B. Daly, Joe Dennis, Thilo Dörk, Laure Dossus, Alison M. Dunning, Miriam Dwek, Arif B. Ekici, A. Heather Eliassen, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Henrik Flyger, Lin Fritschi, Manuela Gago-Domínguez, José Á. García-Sáenz, Graham G. Giles, Mervi Grip, Pascal Guénel, Melanie Gündert, Christopher A. Haiman, Niclas Håkansson, Per Hall, Ute Hamann, Steven N. Hart, Jaana M. Hartikainen, Arndt Hartmann, Wei He, Maartje J. Hooning, Reiner Hoppe, John L. Hopper, Anthony Howell, David J. Hunter, Deborah J. Marsh, Rodney J. Scott, Robert Baxter, Desmond Yip, Jane Carpenter, Alison Davis, Nirmala Pathmanathan, Peter T. Simpson, J. Dinny Graham, Mythily Sachchithananthan, Agnes Jager, Anna Jakubowska, Wolfgang Janni, Esther M. John, Audrey Jung, Rudolf Kaaks, Machteld Keupers, Cari M. Kitahara, Stella Koutros, Peter Kraft, Vessela N. Kristensen, Allison W. Kurian, James V. Lacey, Diether Lambrechts, Loı̈c Le Marchand, Annika Lindblom, Martha S. Linet, Robert Luben, Jan Lubiński, Michael Lush, Mehdi Manoochehri, Sara Margolin, John W.M. Martens, Marı́a Elena Martı́nez, Dimitrios Mavroudis, Kyriaki Michailidou, Roger L. Milne, Anna Marie Mulligan, Taru Muranen, Heli Nevanlinna, William G. Newman, Sune F. Nielsen, Børge G. Nordestgaard, Andrew F. Olshan, Håkan Olsson, Nick Orr, Tjoung‐Won Park‐Simon, Alpa V. Patel, Bernard Peissel, Paolo Peterlongo, Dijana Plaseska‐Karanfilska, Karolina Prajzendanc, Ross L. Prentice, Nadège Presneau, Brigitte Rack, Gad Rennert, Hedy S. Rennert, Valerie Rhenius, Atocha Romero, Rebecca Roylance, Matthias Ruebner, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Andreas Schneeweiß, Christopher J. Scott, Mitul Shah, Snezhana Smichkoska, Melissa C. Southey, Jennifer Stone, Harald Surowy, Anthony J. Swerdlow, Rulla M. Tamimi, William Tapper, Lauren R. Teras, Mary Beth Terry, Rob A.�E.�M. Tollenaar, Ian Tomlinson, Melissa A. Troester, Thérèse Truong, Celine M. Vachon, Qin Wang, Amber N. Hurson, Robert Winqvist, Alicja Wolk, Argyrios Ziogas, Hiltrud Brauch, Montserrat García‐Closas, Paul D.P. Pharoah, Douglas F. Easton, Georgia Chenevix‐Trench, Marjanka K. Schmidt

Bibliographic record

VenueBreast Cancer Research · 2021
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversity Health NetworkLunenfeld-Tanenbaum Research InstituteUniversity of TorontoMount Sinai Hospital
FundersFP7 Ideas: European Research CouncilMedical Research and Materiel CommandServicio Gallego de SaludUniversitätsklinikum Hamburg-EppendorfInstituto de Salud Carlos IIICancer Council NSWNational Health and Medical Research CouncilWorld Cancer Research FundMedical Research CouncilCanadian Institutes of Health ResearchProgramme Grants for Applied ResearchManchester Biomedical Research CentreUniversity of California, San FranciscoImperial Experimental Cancer Medicine CentreNational Institutes of HealthHellenic Health FoundationFreistaat SachsenDeutschen Konsortium für Translationale KrebsforschungXunta de GaliciaMutuelle Générale de l'Education NationaleInstitut Gustave-RoussyNorges ForskningsrådCenters for Disease Control and PreventionInstitut National Du CancerLeids Universitair Medisch CentrumAssociazione Italiana per la Ricerca sul CancroKWF KankerbestrijdingFondation de FranceInstitut National de la Santé et de la Recherche MédicaleUniversity of CreteVetenskapsrådetStockholms Läns LandstingKuopion Yliopistollinen SairaalaHarvard T.H. Chan School of Public HealthKarolinska InstitutetGovernment of CanadaMinisterio de Sanidad, Servicios Sociales e IgualdadOvarian Cancer Research FundBundesministerium für Bildung und ForschungMinisterio de Economía y CompetitividadCancer AustraliaAgence Nationale de la RechercheDeutsche Gesetzliche UnfallversicherungGentofte HospitalDeutsche ForschungsgemeinschaftRobert Bosch StiftungNational Institute of Environmental Health SciencesU.S. ArmyUniversity of WestminsterCancer Council South AustraliaAmerican Cancer SocietyFonds Wetenschappelijk OnderzoekCancerfondenNational Cancer InstituteCancer Institute NSWNational Breast Cancer FoundationCancer Council Western AustraliaEuropean CommissionEuropean Regional Development FundKing's College LondonNational Institute for Health and Care ResearchEberhard Karls Universität TübingenRheinische Friedrich-Wilhelms-Universität BonnBreast Cancer Research TrustFondation du cancer du sein du QuébecUniversity of Southern CaliforniaStavros Niarchos FoundationDeutsche KrebshilfeMinistère de l'Économie, de la Science et de l'Innovation - QuébecUniversity of CaliforniaDavid F. and Margaret T. Grohne Family FoundationCancer Research UKU.S. Department of DefenseItä-Suomen YliopistoGenome CanadaSundhed og Sygdom, Det Frie ForskningsrådCentre International de Recherche sur le CancerLigue Contre le CancerDeutsches KrebsforschungszentrumBrigham and Women's HospitalCancer Council VictoriaCalifornia Department of Public HealthBreast Cancer Research FoundationCancer Council TasmaniaWorld Health Organization
KeywordsBreast cancerHazard ratioMedicineOncologyInternal medicineSurgical oncologyConfidence intervalGermlineCancerProportional hazards modelAlleleBiologyGenetics

Abstract

fetched live from OpenAlex

BACKGROUND: Given the high heterogeneity among breast tumors, associations between common germline genetic variants and survival that may exist within specific subgroups could go undetected in an unstratified set of breast cancer patients. METHODS: We performed genome-wide association analyses within 15 subgroups of breast cancer patients based on prognostic factors, including hormone receptors, tumor grade, age, and type of systemic treatment. Analyses were based on 91,686 female patients of European ancestry from the Breast Cancer Association Consortium, including 7531 breast cancer-specific deaths over a median follow-up of 8.1 years. Cox regression was used to assess associations of common germline variants with 15-year and 5-year breast cancer-specific survival. We assessed the probability of these associations being true positives via the Bayesian false discovery probability (BFDP < 0.15). RESULTS: Evidence of associations with breast cancer-specific survival was observed in three patient subgroups, with variant rs5934618 in patients with grade 3 tumors (15-year-hazard ratio (HR) [95% confidence interval (CI)] 1.32 [1.20, 1.45], P = 1.4E-08, BFDP = 0.01, per G allele); variant rs4679741 in patients with ER-positive tumors treated with endocrine therapy (15-year-HR [95% CI] 1.18 [1.11, 1.26], P = 1.6E-07, BFDP = 0.09, per G allele); variants rs1106333 (15-year-HR [95% CI] 1.68 [1.39,2.03], P = 5.6E-08, BFDP = 0.12, per A allele) and rs78754389 (5-year-HR [95% CI] 1.79 [1.46,2.20], P = 1.7E-08, BFDP = 0.07, per A allele), in patients with ER-negative tumors treated with chemotherapy. CONCLUSIONS: We found evidence of four loci associated with breast cancer-specific survival within three patient subgroups. There was limited evidence for the existence of associations in other patient subgroups. However, the power for many subgroups is limited due to the low number of events. Even so, our results suggest that the impact of common germline genetic variants on breast cancer-specific survival might be limited.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.515
Threshold uncertainty score0.556

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.030
GPT teacher head0.348
Teacher spread0.318 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations23
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueBreast Cancer ResearchSame topicBRCA gene mutations in cancerFrench-language works237,207